Chronic subclinical inflammation is a central process in the pathogenesis of cardiovascular
disease (CVD) and it has been linked with both the initiation and progression of …

Background and aims To evaluate the association between anti-inflammatory therapies and
the incidence of cardiovascular events in patients with established cardiovascular disease …

Cardiovascular disease (CVD) is the leading cause of death. Although once considered
merely as a lipid storage disease, studies indicate the role of inflammation in initiation and …

Atherosclerosis is a chronic inflammatory disorder of the vasculature where cholesterol
accumulates in the arterial wall stimulating infiltration of immune cells. This plays an …

Cardiovascular disorders (CVDs) represent a global challenge and are regarded as one of
the leading causes of mortality. The role of inflammation as a risk factor in these disorders …

Background The inflammation hypothesis of atherosclerosis has been put forward for more
than 20 years. Although many animal experiments have suggested that anti-inflammatory …

Cardiovascular disease (CVD) has been associated with the so-called traditional risk
factors, such as hypertension, hypercholesterolemia and cigarette smoking. Chronic …

Inflammation is a pathogenic response to multiple factors, that causes over-activation of
different molecules and pro-inflammatory cellular lines. Different behavioral factors and risk …

Approximately 40% of heart attack survivors remain at increased risk of recurrent
cardiovascular events, despite the current treatment options showing that atherothrombosis …

Background: Anti-inflammatory therapy has been proposed as a promising treatment for
coronary heart disease (CHD) that could reduce residual inflammation risk (RIR) and …